{ "items" : [
    { "id" : "http://dbpedia.org/resource/Gardasil"
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "Gardasil (Merck & Co.), also known as Gardisil or Silgard or recombinant human papillomavirus vaccine [types 6, 11, 16, 18], is a vaccine for use in the prevention of certain strains of human papillomavirus (HPV), specifically HPV types 6, 11, 16 and 18. HPV types 16 and 18 cause an estimated 70% of cervical cancers, and are responsible for most HPV-induced anal, vulvar, vaginal, and penile cancer cases. HPV types 6 and 11 cause an estimated 90% of genital warts cases." ] ,
        "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ "http://dbpedia.org/resource/HPV_vaccines" ] ,
        "http://xmlns.com/foaf/0.1/depiction" : [ "http://commons.wikimedia.org/wiki/Special:FilePath/Gardasil_vaccine_and_box_new.jpg" ] ,
        "http://dbpedia.org/ontology/atcPrefix" : [ "J07" ] ,
        "http://dbpedia.org/ontology/atcSuffix" : [ "BM01" ] ,
        "http://dbpedia.org/ontology/thumbnail" : [ "http://commons.wikimedia.org/wiki/Special:FilePath/Gardasil_vaccine_and_box_new.jpg?width=300"] } } }
